Table 4.
Prognostic factors for progression-free survival in univariable and multivariable analyses.
| Factor | Univariable Analysis | Multivariable Analysis | ||
|---|---|---|---|---|
| Hazard Ratio (95% CI) | p-Value | Hazard Ratio (95% CI) | p-Value | |
| Hsa_circ_0003570 (high expression) | 0.580 (0.388–0.867) | 0.008 * | 0.633 (0.402–0.997) | 0.048 * |
| Age (>60 years) | 0.887 (0.600–1.311) | 0.548 | 0.919 (0.575–1.467) | 0.723 |
| Sex (Male) | 1.216 (0.713–2.076) | 0.473 | 1.719 (0.945–3.125) | 0.076 |
| Tumor number (multiple) | 1.950 (1.316–2.889) | 0.001 * | 0.754 (0.455–1.248) | 0.272 |
| AFP (>200 ng/mL) | 2.767 (1.845–4.148) | <0.001 * | 1.569 (0.963–2.557) | 0.070 |
| CTP classification (B vs. A) | 2.869 (1.676–4.911) | <0.001 * | 2.163 (1.098–4.261) | 0.026 * |
| Chronic hepatitis B | 0.766 (0.514–1.141) | 0.190 | 0.967 (0.614–1.526) | 0.887 |
| Curative treatment | 0.186 (0.120–0.288) | <0.001 * | 0.235 (0.133–0.416) | <0.001 * |
CI—confidence interval; AFP—α-fetoprotein; CTP—Child–Turcotte–Pugh. * p < 0.05.